A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...

Is Soda Bad for You? We don’t love labeling foods and beverages “good” or “bad” — not even soda. This sort of black-and-white thinking doesn’t do ...

Getting old doesn't have to mean getting frail. A landmark trial suggests stem cells can reverse the physical decline of ageing ...

Newsweek spoke to a doctor about a recent study that suggests this daily drink may help calm chronic inflammation.

Most people believe that you get a blocked nose only during common colds, but the fact is, even during a regular day, only one nostril allows air in. The nostrils switch between a dominant one for air ...

The NF-κB-inducing kinase (NIK), a molecule pivotal for immune system development and function, shows significant yet complex potential as a therapeutic target. The comprehensive review, published by ...

The results show how relatively small dietary adjustments could influence the course of disease. According to the researchers ...

As populations age worldwide, the decline of the immune system, a process known as immunosenescence, has become a critical biomedical challenge. This decline leads to increased susceptibility to ...

Maintaining mobility and flexibility are crucial to living a full life. But stiff, sore, or painful joints can get in the way ...

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells—also known as "zombie cells"—in diabetic kidney ...

The impact of neflamapimod on neurofilament light levels will be examined in a study of approximately 35 patients with ALS, facilitated by the EXPERTS-ALS platform, according to a press release from ...